GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen YHLO Biotech Co Ltd (SHSE:688575) » Definitions » 5-Year EBITDA Growth Rate

Shenzhen YHLO Biotech Co (SHSE:688575) 5-Year EBITDA Growth Rate : 24.40% (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shenzhen YHLO Biotech Co 5-Year EBITDA Growth Rate?

Shenzhen YHLO Biotech Co's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.03.

During the past 12 months, Shenzhen YHLO Biotech Co's average EBITDA Per Share Growth Rate was -15.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 16.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 24.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shenzhen YHLO Biotech Co was 112.00% per year. The lowest was 13.70% per year. And the median was 55.50% per year.


Competitive Comparison of Shenzhen YHLO Biotech Co's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen YHLO Biotech Co's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shenzhen YHLO Biotech Co's 5-Year EBITDA Growth Rate falls into.


;
;

Shenzhen YHLO Biotech Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Shenzhen YHLO Biotech Co  (SHSE:688575) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Shenzhen YHLO Biotech Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shenzhen YHLO Biotech Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen YHLO Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Baolong 2nd Road, Baolong Street, Building 1, Yahuilong Biological Technology Factory, Longgang District, Guangdong, Shenzhen, CHN, 518116
Shenzhen YHLO Biotech Co Ltd is an innovative enterprise focusing on overall clinical laboratory solutions with leading domestic technology and integrated research, production and marketing. Its main business is research and development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay.
Executives
Song Yong Bo Directors, senior managers
Xiao Yu Jin senior management
Liao Li Sheng Directors, senior managers
Pang Shi Hong senior management
Hu Kun Hui Director
Xia Fu Zhen Core technical personnel

Shenzhen YHLO Biotech Co Headlines

No Headlines